HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children

The human leukocyte antigen (HLA) allele group HLA-DQA1*05 predisposes to ulcerative colitis (UC) and is associated with the development of antibodies against infliximab in patients with inflammatory bowel disease (IBD). Therefore, we hypothesized that the presence of HLA-DQA1*05 correlates with cha...

Full description

Bibliographic Details
Main Authors: Jan Krzysztof Nowak, Aleksandra Glapa-Nowak, Aleksandra Banaszkiewicz, Barbara Iwańczak, Jarosław Kwiecień, Anna Szaflarska-Popławska, Urszula Grzybowska-Chlebowczyk, Marcin Osiecki, Jarosław Kierkuś, Magdalena Hołubiec, Justyna Chanaj-Kaczmarek, Andrzej Radzikowski, Jarosław Walkowiak
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/12/12/1934
_version_ 1797504300864241664
author Jan Krzysztof Nowak
Aleksandra Glapa-Nowak
Aleksandra Banaszkiewicz
Barbara Iwańczak
Jarosław Kwiecień
Anna Szaflarska-Popławska
Urszula Grzybowska-Chlebowczyk
Marcin Osiecki
Jarosław Kierkuś
Magdalena Hołubiec
Justyna Chanaj-Kaczmarek
Andrzej Radzikowski
Jarosław Walkowiak
author_facet Jan Krzysztof Nowak
Aleksandra Glapa-Nowak
Aleksandra Banaszkiewicz
Barbara Iwańczak
Jarosław Kwiecień
Anna Szaflarska-Popławska
Urszula Grzybowska-Chlebowczyk
Marcin Osiecki
Jarosław Kierkuś
Magdalena Hołubiec
Justyna Chanaj-Kaczmarek
Andrzej Radzikowski
Jarosław Walkowiak
author_sort Jan Krzysztof Nowak
collection DOAJ
description The human leukocyte antigen (HLA) allele group HLA-DQA1*05 predisposes to ulcerative colitis (UC) and is associated with the development of antibodies against infliximab in patients with inflammatory bowel disease (IBD). Therefore, we hypothesized that the presence of HLA-DQA1*05 correlates with characteristics of pediatric IBD. Within a multi-center cohort in Poland, the phenotype at diagnosis and worst flare was established and HLA-DQA1*05 status was assessed enabling genotype-phenotype analyses. HLA-DQA1*05 was present in 221 (55.1%) out of 401 children with IBD (UC <i>n</i> = 188, Crohn’s disease <i>n</i> = 213). In UC, the presence of HLA-DQA1*05 was moderately associated with a large extent of colonic inflammation at diagnosis (E4 55% more frequent in HLA-DQA1*05-positive patients, <i>p</i> = 0.012). PUCAI at diagnosis (<i>p</i> = 0.078) and the time from UC diagnosis to the first administration of biologic treatment (<i>p</i> = 0.054) did not differ depending on HLA-DQA1*05 status. The number of days of hospitalization for exacerbation was analyzed in 98 patients for whom sufficient follow-up was available and did not differ depending on HLA-DQA1*05 carriership (<i>p</i> = 0.066). HLA-DQA1*05 carriers with CD were less likely to present with both stenosing and penetrating disease (B2B3, <i>p</i> = 0.048) and to have active disease proximal to the ligament of Treitz (L4a) at the worst flare (<i>p</i> = 0.046). Future research focusing on explaining and preventing anti-TNF immunogenicity should take into account that ADA may develop not only as an isolated reaction to anti-TNF exposure but also as a consequence of intrinsic differences in the early course of UC.
first_indexed 2024-03-10T04:02:41Z
format Article
id doaj.art-b03664dc3bea4db5b9e35ccdeea67501
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-10T04:02:41Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-b03664dc3bea4db5b9e35ccdeea675012023-11-23T08:30:35ZengMDPI AGGenes2073-44252021-11-011212193410.3390/genes12121934HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in ChildrenJan Krzysztof Nowak0Aleksandra Glapa-Nowak1Aleksandra Banaszkiewicz2Barbara Iwańczak3Jarosław Kwiecień4Anna Szaflarska-Popławska5Urszula Grzybowska-Chlebowczyk6Marcin Osiecki7Jarosław Kierkuś8Magdalena Hołubiec9Justyna Chanaj-Kaczmarek10Andrzej Radzikowski11Jarosław Walkowiak12Department of Pediatric Gastroenterology and Metabolic Diseases, Poznań University of Medical Sciences, Szpitalna 27/33, 60-572 Poznań, PolandDepartment of Pediatric Gastroenterology and Metabolic Diseases, Poznań University of Medical Sciences, Szpitalna 27/33, 60-572 Poznań, PolandDepartment of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, 02-091 Warszawa, PolandDepartment and Clinic of Pediatrics, Gastroenterology and Nutrition, Wroclaw Medical University, 50-367 Wrocław, PolandDepartment of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-800 Zabrze, PolandDepartment of Pediatric Endoscopy and Gastrointestinal Function Testing, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-067 Bydgoszcz, PolandDepartment of Pediatrics, Faculty of Medical Sciences, Medical University of Silesia in Katowice, 40-055 Katowice, PolandThe Department of Gastroenterology, Hepatology, Feeding Disorders and Paediatrics, The Children’s Memorial Health Institute, 04-730 Warsaw, PolandThe Department of Gastroenterology, Hepatology, Feeding Disorders and Paediatrics, The Children’s Memorial Health Institute, 04-730 Warsaw, PolandDepartment of Pediatric Gastroenterology and Metabolic Diseases, Poznań University of Medical Sciences, Szpitalna 27/33, 60-572 Poznań, PolandDepartment of Pharmacognosy, Poznan University of Medical Sciences, 4 Święcickiego Street, 60-781 Poznan, PolandDepartment of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, 02-091 Warszawa, PolandDepartment of Pediatric Gastroenterology and Metabolic Diseases, Poznań University of Medical Sciences, Szpitalna 27/33, 60-572 Poznań, PolandThe human leukocyte antigen (HLA) allele group HLA-DQA1*05 predisposes to ulcerative colitis (UC) and is associated with the development of antibodies against infliximab in patients with inflammatory bowel disease (IBD). Therefore, we hypothesized that the presence of HLA-DQA1*05 correlates with characteristics of pediatric IBD. Within a multi-center cohort in Poland, the phenotype at diagnosis and worst flare was established and HLA-DQA1*05 status was assessed enabling genotype-phenotype analyses. HLA-DQA1*05 was present in 221 (55.1%) out of 401 children with IBD (UC <i>n</i> = 188, Crohn’s disease <i>n</i> = 213). In UC, the presence of HLA-DQA1*05 was moderately associated with a large extent of colonic inflammation at diagnosis (E4 55% more frequent in HLA-DQA1*05-positive patients, <i>p</i> = 0.012). PUCAI at diagnosis (<i>p</i> = 0.078) and the time from UC diagnosis to the first administration of biologic treatment (<i>p</i> = 0.054) did not differ depending on HLA-DQA1*05 status. The number of days of hospitalization for exacerbation was analyzed in 98 patients for whom sufficient follow-up was available and did not differ depending on HLA-DQA1*05 carriership (<i>p</i> = 0.066). HLA-DQA1*05 carriers with CD were less likely to present with both stenosing and penetrating disease (B2B3, <i>p</i> = 0.048) and to have active disease proximal to the ligament of Treitz (L4a) at the worst flare (<i>p</i> = 0.046). Future research focusing on explaining and preventing anti-TNF immunogenicity should take into account that ADA may develop not only as an isolated reaction to anti-TNF exposure but also as a consequence of intrinsic differences in the early course of UC.https://www.mdpi.com/2073-4425/12/12/1934inflammatory bowel diseasecolitisCrohn’s diseaseanti-drug antibodiespersonalized medicinehigh-resolution melting
spellingShingle Jan Krzysztof Nowak
Aleksandra Glapa-Nowak
Aleksandra Banaszkiewicz
Barbara Iwańczak
Jarosław Kwiecień
Anna Szaflarska-Popławska
Urszula Grzybowska-Chlebowczyk
Marcin Osiecki
Jarosław Kierkuś
Magdalena Hołubiec
Justyna Chanaj-Kaczmarek
Andrzej Radzikowski
Jarosław Walkowiak
HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children
Genes
inflammatory bowel disease
colitis
Crohn’s disease
anti-drug antibodies
personalized medicine
high-resolution melting
title HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children
title_full HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children
title_fullStr HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children
title_full_unstemmed HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children
title_short HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children
title_sort hla dqa1 05 associates with extensive ulcerative colitis at diagnosis an observational study in children
topic inflammatory bowel disease
colitis
Crohn’s disease
anti-drug antibodies
personalized medicine
high-resolution melting
url https://www.mdpi.com/2073-4425/12/12/1934
work_keys_str_mv AT jankrzysztofnowak hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT aleksandraglapanowak hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT aleksandrabanaszkiewicz hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT barbaraiwanczak hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT jarosławkwiecien hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT annaszaflarskapopławska hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT urszulagrzybowskachlebowczyk hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT marcinosiecki hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT jarosławkierkus hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT magdalenahołubiec hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT justynachanajkaczmarek hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT andrzejradzikowski hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren
AT jarosławwalkowiak hladqa105associateswithextensiveulcerativecolitisatdiagnosisanobservationalstudyinchildren